Prof. Elisa Giovannetti is working in the Department of Medical Oncology, Amsterdam UMC, VU University. She obtained her MD and PhD at the University of Pisa, where she also worked as a clinical fellow in pharmacology, with a special focus on translational studies in pancreatic and lung cancer. Since 2006, she has collaborated with VU University Medical Center to set up a line of research on molecular mechanisms underlying chemoresistance and new biomarkers. She was promoted to associate professor in 2016, received habilitation as a full professor in 2022, and she is also working as the PI of a start-up lab at the Fondazione Pisana per la Scienza, Pisa, Italy. Her research focuses on the study of the mechanism of action and resistance to anticancer agents, as well as in the field of clinical pharmacology. She successfully requested funding from several national and international organizations, including “Marie Curie”, COST and FP7 European Initiatives, the Italian Association for Research against Cancer (AIRC, Start-Up Grant), the Netherlands Organization for Scientific Research (NWO, VENI Grant), Dutch Cancer Society (KWF), and American Mesothelioma Applied Research Foundation. She is actively involved as the elected chair in research projects within the “Pharmacology and Molecular Mechanism Group” group of the EORTC (EORTC-PAMM).